Ann: Half Yearly Report and Accounts, page-30

I don't think the SP is important, merely trying to understand the cost differential as I do not fully understand the concept behind it. I'm interested in a buyout and held for 4+years. Heck, if the SP was $1.80 right now I'd only be taking 10% off the top based on potential buyout scenarios combined with the fact Pfizer and other big pharma haven't been spending as much over the past few years: (https://www.washingtonpost.com/business/seagen-could-be-the-deal-pfizer-investors-have-been-craving/2023/02/27/43a202c8-b6c7-11ed-b0df-8ca14de679ad_story.html) "Pfizer certainly has the motivation to do the deal. The big pharma firm has been under pressure from investors to spend its huge pile of Covid cash" February 28, 2023

Thank you for explaining, makes a lot of sense and interesting to see other companies issue less vs more. I wonder how that affects performance or market fluctuations of a company with less shares on issue vs companies with much more.